Following the observation that Tpl2 expression was also decreased in a NFKB1−/− human lung cancer cell line, Fan Sun and colleagues [39] demonstrated that re-expressing p105, and not p50, restored Tpl2 levels in these cells, resulting in reduced tumour growth. Here, MAP3K8 is linked to lung carcinoma.